Defence Therapeutics (DTC.CN) Q1 2022 Earnings

Jun 21Expected
Q3 2021
Q1 2022
-0.05
-0.05
-0.04
-0.04

Details

Expected EPS
N/A
Actual EPS
-0.0469
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Defence Therapeutics⁩ (⁦DTC.CN⁩) has reported earnings of ⁦-0.0469⁩ per share for ⁦Q1 2022⁩.

0 Comments

Share your thoughts